Scientific Opinion on the substantiation of health claims related to alpha linolenic acid (ALA) and brain and neurological development (ID 491), “molecule precursors regulating cell functions” (ID 492, 4671), maintenance of normal cardiac function (ID 509, 579), “nutrient tasks and interactions” (ID 576), maintenance of normal blood pressure (ID 575), and enhancement of mood (ID 578, 601, 3182) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Alpha-linolenic acid (ALA), brain development, cardiac function, blood pressure, mood, health claims
First published in the EFSA Journal
8 avril 2011
Adopted
28 janvier 2011
Type
Scientific Opinion

Abstract

No abstract available

Panel members at the time of adoption

Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen
Panel on Dietetic Products, Nutrition and Allergies
Contact
nda [at] efsa.europa.eu
doi
10.2903/j.efsa.2011.2050
EFSA Journal 2011;9(4):2050
On request from
European Commission